학술논문

Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
Document Type
Article
Source
In: Neuro-Oncology. (Neuro-Oncology, 1 February 2023, 25(2):386-397)
Subject
Language
English
ISSN
15235866
15228517